Want to see GB:APN full AI Analyst Report?
Top Page
Applied Nutrition PLC
(LSE:APN)
Select Model
Select Model
Rating:77Outperform
Price Target:
365.00 p
▲(13.53% Upside)
Action:Reiterated
Date:08/26/26
The score is anchored by strong financial performance (rapid growth, low leverage, and robust free cash flow) and positive corporate events (upgraded outlook plus strategic U.S. expansion and major licensing tie-up). These strengths are tempered by weak near-term technical momentum and a relatively high P/E with no dividend yield provided.
Positive Factors
Rapid Revenue and Profit Growth
Sustained revenue expansion alongside rising net income indicates strong product demand and operating scale. Continued growth can support broader distribution, improve fixed-cost absorption and strengthen the company’s competitive position over the next several periods.
Negative Factors
Margin Pressure from Product Mix and Input Costs
Margin softening could limit how much of the company’s rapid sales growth converts into profit. Product-mix changes and whey-cost inflation may persist as the business scales, requiring pricing, sourcing and operating discipline to protect earnings quality.
Read all positive and negative factors
Positive Factors
Negative Factors
Rapid Revenue and Profit Growth
Sustained revenue expansion alongside rising net income indicates strong product demand and operating scale. Continued growth can support broader distribution, improve fixed-cost absorption and strengthen the company’s competitive position over the next several periods.
Read all positive factors
Applied Nutrition PLC (APN) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£767.50M
Dividend YieldN/A
Average Volume (3M)755.53K
Price to Earnings (P/E)27.8
Beta (1Y)0.72
Revenue GrowthN/A
EPS GrowthN/A
CountryUK
Employees270
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)0.11
Shares Outstanding250,000,000
10 Day Avg. Volume1,556,042
30 Day Avg. Volume755,529
Financial Highlights & Ratios
PEG Ratio1.18
Price to Book (P/B)6.03
Price to Sales (P/S)3.06
P/FCF Ratio21.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£361.67Price Target Upside12.49% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.14
Revenue Forecast (FY)£204.84M
Applied Nutrition PLC Business Overview & Revenue Model
Company Description
Applied Nutrition Plc, established in 2014 and based in Liverpool, United Kingdom, specializes in the international manufacture, wholesale, and retail of sports nutritional products. Its comprehensive product portfolio includes a diverse array of ...
How the Company Makes Money
APN makes money primarily by selling branded nutrition and supplement products. Revenue is generated through (1) wholesale and distribution sales to retailers and resellers (e.g., gyms, specialty nutrition stores, and other trade customers), where...
Applied Nutrition PLC Financial Statement Overview
Summary
Income Statement
92
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
86
Very Positive
| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 134.00M | 107.10M | 86.15M | 60.78M | 35.03M |
| Gross Profit | 60.40M | 48.20M | 40.38M | 26.51M | 13.61M |
| EBITDA | 38.90M | 29.70M | 25.38M | 18.61M | 10.42M |
| Net Income | 27.60M | 21.10M | 18.65M | 13.82M | 8.21M |
Balance Sheet | |||||
| Total Assets | 98.90M | 75.00M | 59.65M | 40.62M | 22.11M |
| Cash, Cash Equivalents and Short-Term Investments | 26.40M | 18.50M | 18.72M | 12.73M | 5.40M |
| Total Debt | 3.10M | 3.00M | 1.80M | 2.06M | 1.13M |
| Total Liabilities | 29.30M | 20.70M | 11.63M | 11.87M | 7.24M |
| Stockholders Equity | 69.60M | 54.30M | 48.02M | 28.75M | 14.87M |
Cash Flow | |||||
| Free Cash Flow | 16.30M | 15.20M | 6.28M | 7.62M | 6.20M |
| Operating Cash Flow | 17.20M | 16.20M | 7.32M | 8.59M | 6.49M |
| Investing Cash Flow | -900.00K | -1.00M | -407.00K | -989.00K | -267.00K |
| Financing Cash Flow | -800.00K | -15.10M | -339.00K | -217.00K | -8.98M |
Applied Nutrition PLC Technical Analysis
Neutral
321.50
Price Trends
324.56
Negative
285.45
Positive
257.34
Positive
Market Momentum
-4.20
Positive
39.00
Neutral
6.86
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:APN, the sentiment is Neutral. The current price of 321.5 is below the 20-day moving average (MA) of 324.57, below the 50-day MA of 324.56, and above the 200-day MA of 257.34, indicating a neutral trend. The MACD of -4.20 indicates Positive momentum. The RSI at 39.00 is Neutral, neither overbought nor oversold. The STOCH value of 6.86 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for GB:APN.
Applied Nutrition PLC Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £1.68B | 12.72 | 9.74% | 1.72% | 2.31% | 9.04% | |
77 Outperform | £767.50M | 27.81 | 44.55% | ― | ― | ― | |
67 Neutral | £14.48B | 15.46 | 8.44% | 3.04% | -2.16% | -24.87% | |
65 Neutral | £2.80B | 17.79 | 14.99% | 2.15% | 9.52% | 18.08% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | £2.47B | 25.14 | 6.17% | 3.55% | 15.55% | 42.40% | |
57 Neutral | £2.02B | 81.79 | 0.73% | 1.02% | 25.76% | -73.03% |
* Consumer Defensive Sector Average
GB:APN
Applied Nutrition PLC
307.00
143.60
87.88%
GB:ABF
Associated British Foods
2,072.00
-96.36
-4.44%
GB:CWK
Cranswick
5,230.00
264.59
5.33%
GB:PFD
Premier Foods
195.40
12.24
6.68%
GB:TATE
Tate & Lyle
558.00
64.99
13.18%
GB:GNC
Greencore
255.20
12.28
5.06%
Applied Nutrition PLC Corporate Events
Business Operations and StrategyFinancial Disclosures
Applied Nutrition lifts FY26 guidance and signals further growth despite margin pressure
Positive
Aug 26, 2026
Applied Nutrition reported that for the year to 31 July 2026, adjusted EBITDA is expected to rise 40% to about £43.3m and revenue 50% to £160m, both ahead of market expectations, driven by strong demand across its markets and channels. T...
Business Operations and StrategyExecutive/Board Changes
Applied Nutrition Non-Executive Director Takes Role at Beauty Tech Group
Positive
Jun 30, 2026
Applied Nutrition PLC has noted a change in its board commitments, announcing that non-executive director Marnie Millard will join The Beauty Tech Group PLC as a non-executive director from 1 July 2026. The appointment underscores the cross-sector...
Regulatory Filings and Compliance
Applied Nutrition CFO Disposes of 550,000 Shares in Market-Regulated Trade
Neutral
Jun 4, 2026
Applied Nutrition plc has disclosed a share transaction involving its chief financial officer, Joe Pollard, in line with market abuse regulations. The company reported that Pollard, classified as a person discharging managerial responsibilities, h...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsProduct-Related Announcements
Applied Nutrition lifts outlook, buys U.S. plant and seals Mondelēz tie-up
Positive
Jun 1, 2026
Applied Nutrition plc has upgraded its guidance for the year to 31 July 2026, now forecasting revenue of about £148 million with EBITDA margins in line with market expectations, reflecting strong trading momentum. The company signalled that c...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.